Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot # G510086; Exp. 11/17
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Lupin Limited
- Reason for Recall:
- Labeling: Incorrect or Missing Lot and/or Expiration Date
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01
Product Codes/Lot Numbers:
Lot # G510086; Exp. 11/17
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-1516-201
Related Recalls
Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.